Might want to keep an eye on this one. Might take off if its studies prove usefull.
AVI BioPharma (AVII: 3.69, +0.43, +13.2%), a little-known U.S. biotechnology firm, also could be a beneficiary of flu fears because its novel "antisense" drugs may be effective in combating the flu virus, as well as hepatitis C and a range of bio-terror threats, including the dreaded Ebola virus.